The association between tyrosine kinase inhibitors and fatal arrhythmia in patients with non-small cell lung cancer in Taiwan

OBJECTIVE: As a standard therapy, tyrosine kinase inhibitors (TKIs) improved survival in patients with non-small cell lung cancer (NSCLC) and epidermal growth factor receptor (EGFR) mutation. However, treatment-related cardiotoxicity, particularly arrhythmia, cannot be ignored. With the prevalence o...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Wei-Ting, Lin, Hui-Wen, Chang, Ting-Chia, Lin, Sheng-Hsiang, Li, Yi-Heng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150998/
https://www.ncbi.nlm.nih.gov/pubmed/37139162
http://dx.doi.org/10.3389/fonc.2023.1172036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150998/
https://www.ncbi.nlm.nih.gov/pubmed/37139162
http://dx.doi.org/10.3389/fonc.2023.1172036

Ejemplares similares